Literature DB >> 7568173

Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5.

L Robb1, C C Drinkwater, D Metcalf, R Li, F Köntgen, N A Nicola, C G Begley.   

Abstract

Gene targeting was used to create mice with a null mutation of the gene encoding the common beta subunit (beta C) of the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin 3 (IL-3; multi-CSF), and interleukin 5 (IL-5) receptor complexes (beta C-/- mice). High-affinity binding of GM-CSF was abolished in beta C-/- bone marrow cells, while cells from heterozygous animals (beta C+/- mice) showed an intermediate number of high-affinity receptors. Binding of IL-3 was unaffected, confirming that the IL-3-specific beta chain remained intact. Eosinophil numbers in peripheral blood and bone marrow of beta C-/- animals were reduced, while other hematological parameters were normal. In clonal cultures of beta C-/- bone marrow cells, even high concentrations of GM-CSF and IL-5 failed to stimulate colony formation, but the cells exhibited normal quantitative responsiveness to stimulation by IL-3 and other growth factors. beta C-/- mice exhibited normal development and survived to young adult life, although they developed pulmonary peribronchovascular lymphoid infiltrates and areas resembling alveolar proteinosis. There was no detectable difference in the systemic clearance and distribution of GM-CSF between beta C-/- and wild-type littermates. The data establish that beta C is normally limiting for high-affinity binding of GM-CSF and demonstrate that systemic clearance of GM-CSF is not mediated via such high-affinity receptor complexes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568173      PMCID: PMC40842          DOI: 10.1073/pnas.92.21.9565

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Macrophages specifically regulate the concentration of their own growth factor in the circulation.

Authors:  A Bartocci; D S Mastrogiannis; G Migliorati; R J Stockert; A W Wolkoff; E R Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

2.  Binding of iodinated multipotential colony-stimulating factor (interleukin-3) to murine bone marrow cells.

Authors:  N A Nicola; D Metcalf
Journal:  J Cell Physiol       Date:  1986-08       Impact factor: 6.384

3.  bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship.

Authors:  A Strasser; A W Harris; S Cory
Journal:  Cell       Date:  1991-11-29       Impact factor: 41.582

4.  Tissue localization and fate in mice of injected multipotential colony-stimulating factor.

Authors:  D Metcalf; N A Nicola
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

5.  Cloning of an interleukin-3 receptor gene: a member of a distinct receptor gene family.

Authors:  N Itoh; S Yonehara; J Schreurs; D M Gorman; K Maruyama; A Ishii; I Yahara; K Arai; A Miyajima
Journal:  Science       Date:  1990-01-19       Impact factor: 47.728

6.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene.

Authors:  V L Tybulewicz; C E Crawford; P K Jackson; R T Bronson; R C Mulligan
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

7.  Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor.

Authors:  J E Layton; H Hockman; W P Sheridan; G Morstyn
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

8.  Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor.

Authors:  K Hayashida; T Kitamura; D M Gorman; K Arai; T Yokota; A Miyajima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

9.  Selective up-regulation of macrophage function in granulocyte-macrophage colony-stimulating factor transgenic mice.

Authors:  M J Elliott; A Strasser; D Metcalf
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

10.  Hemopoietic responses in mice injected with purified recombinant murine GM-CSF.

Authors:  D Metcalf; C G Begley; D J Williamson; E C Nice; J De Lamarter; J J Mermod; D Thatcher; A Schmidt
Journal:  Exp Hematol       Date:  1987-01       Impact factor: 3.084

View more
  70 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

2.  IL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease.

Authors:  Stephane Wong; Jami McLaughlin; Donghui Cheng; Kevin Shannon; Lorraine Robb; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

3.  CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.

Authors:  Kylie A Alexander; Ryan Flynn; Katie E Lineburg; Rachel D Kuns; Bianca E Teal; Stuart D Olver; Mary Lor; Neil C Raffelt; Motoko Koyama; Lucie Leveque; Laetitia Le Texier; Michelle Melino; Kate A Markey; Antiopi Varelias; Christian Engwerda; Jonathan S Serody; Baptiste Janela; Florent Ginhoux; Andrew D Clouston; Bruce R Blazar; Geoffrey R Hill; Kelli P A MacDonald
Journal:  J Clin Invest       Date:  2014-08-26       Impact factor: 14.808

Review 4.  The molecular basis of pulmonary alveolar proteinosis.

Authors:  Brenna Carey; Bruce C Trapnell
Journal:  Clin Immunol       Date:  2010-03-25       Impact factor: 3.969

5.  Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch.

Authors:  Mark A Guthridge; Jason A Powell; Emma F Barry; Frank C Stomski; Barbara J McClure; Hayley Ramshaw; Fernando A Felquer; Mara Dottore; Daniel T Thomas; Bik To; C Glenn Begley; Angel F Lopez
Journal:  EMBO J       Date:  2006-01-26       Impact factor: 11.598

6.  Autoantibody-Mediated Pulmonary Alveolar Proteinosis in Rasgrp1-Deficient Mice.

Authors:  Andrew Ferretti; Jarrod R Fortwendel; Sarah A Gebb; Robert A Barrington
Journal:  J Immunol       Date:  2016-06-08       Impact factor: 5.422

7.  Genome-wide search for genes that modulate inflammatory arthritis caused by Ali18 mutation in mice.

Authors:  Koichiro Abe; Matthias Klaften; Akira Narita; Tetsuaki Kimura; Kenji Imai; Minoru Kimura; Isabel Rubio-Aliaga; Sibylle Wagner; Thilo Jakob; Martin Hrabé de Angelis
Journal:  Mamm Genome       Date:  2009-02-24       Impact factor: 2.957

8.  Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.

Authors:  Yoshikazu Inoue; Bruce C Trapnell; Ryushi Tazawa; Toru Arai; Toshinori Takada; Nobuyuki Hizawa; Yasunori Kasahara; Koichiro Tatsumi; Masaaki Hojo; Toshio Ichiwata; Naohiko Tanaka; Etsuro Yamaguchi; Ryosuke Eda; Kazunori Oishi; Yoshiko Tsuchihashi; Chinatsu Kaneko; Toshihiro Nukiwa; Mitsunori Sakatani; Jeffrey P Krischer; Koh Nakata
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

9.  Pulmonary pharmacodynamics of an anti-GM-CSFRα antibody enables therapeutic dosing that limits exposure in the lung.

Authors:  Jamie Campbell; Josquin Nys; Laura Eghobamien; E Suzanne Cohen; Matthew J Robinson; Matthew A Sleeman
Journal:  MAbs       Date:  2016-08-12       Impact factor: 5.857

10.  The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues.

Authors:  Claudia Waskow; Kang Liu; Guillaume Darrasse-Jèze; Pierre Guermonprez; Florent Ginhoux; Miriam Merad; Tamara Shengelia; Kaihui Yao; Michel Nussenzweig
Journal:  Nat Immunol       Date:  2008-05-11       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.